Chang, Emalyn C.
HRN: 25-94-22 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/23/2024
CEFTRIAXONE 1G (VIAL)
09/23/2024
09/30/2024
IV
2G
OD
PMBO
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes